Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama.
Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
J Surg Res. 2023 Jan;281:185-191. doi: 10.1016/j.jss.2022.07.027. Epub 2022 Sep 27.
Total thyroidectomy (TT) has been shown to be a safe and effective treatment for Graves' disease. However, the time course for improvement of symptoms has not been defined.
With an institutional review board approval, we prospectively gathered survey data of all patients (n = 79) undergoing TT for Graves' disease at a single institution from 2019 to 2021. After informed consent was obtained, patients completed surveys preoperatively and at 2 wk followed by monthly postoperative visits/phone calls. Patient demographics and survey results were collected and analyzed. Symptom recovery time was evaluated using Kaplan-Meier analysis.
A total of 50 patients completed the survey on postoperative follow-up (response rate 63%). Average age was 38 y (range 12-80 y) and 88% of patients were female. The most common preoperative symptoms were fatigue (90%) and heat/cold intolerance (88%). Tremor (median time to resolution: 1 wk; interquartile range [IQR] 1-3), diarrhea (median 1 wk [IQR 1-3]), and palpitations (median 1 wk [IQR 1-3]) resolved the most rapidly followed by eye symptoms (median 3 wk [IQR 1-6]), heat/cold intolerance (median 3 wk [IQR 3-30]), memory deficits (median 3 wk [IQR 1-undefined]), and fatigue (median: 3 wk [IQR 1-14]). There were no significant differences in time to resolution of symptoms by gender or age (less than versus 40 y and older). Those with uncontrolled Graves' had more severe symptoms but no difference in time to resolution from the euthyroid Graves' patients.
Many Graves' disease symptoms improve rapidly following TT, with a median time to improvement of less than 1 mo.
全甲状腺切除术(TT)已被证明是治疗格雷夫斯病的一种安全有效的方法。然而,症状改善的时间进程尚未确定。
在机构审查委员会批准下,我们前瞻性地收集了 2019 年至 2021 年期间在一家机构接受 TT 治疗的格雷夫斯病患者(n=79)的调查数据。在获得知情同意后,患者在术前和术后 2 周进行了调查,随后每月进行术后随访/电话随访。收集并分析患者的人口统计学和调查结果。使用 Kaplan-Meier 分析评估症状恢复时间。
共有 50 名患者完成了术后随访调查(应答率为 63%)。平均年龄为 38 岁(范围 12-80 岁),88%的患者为女性。术前最常见的症状是疲劳(90%)和对冷热敏感(88%)。震颤(中位缓解时间:1 周;四分位距 [IQR] 1-3)、腹泻(中位 1 周 [IQR 1-3])和心悸(中位 1 周 [IQR 1-3])缓解最快,其次是眼部症状(中位 3 周 [IQR 1-6])、对冷热敏感(中位 3 周 [IQR 3-30])、记忆力减退(中位 3 周 [IQR 1-未定义])和疲劳(中位:3 周 [IQR 1-14])。症状缓解时间在性别或年龄上(<40 岁与≥40 岁)没有显著差异。未经控制的格雷夫斯病患者的症状更严重,但与甲状腺功能正常的格雷夫斯病患者相比,症状缓解时间没有差异。
格雷夫斯病患者在 TT 后许多症状迅速改善,中位改善时间不到 1 个月。